文献速递妇科母胎医学

母乳喂养对BRCA1/2突变携带者卵巢癌的预防作用:系统综述与荟萃分析

The preventive effect of breastfeeding against ovarian cancer in BRCA1 and BRCA2 mutation carriers: A systematic review and meta-analysis.
PubMed 文献 · Gynecol Oncol · 2021-07-23

该系统综述与荟萃分析纳入5项研究(1项队列和4项病例对照),共14,601例BRCA1/2突变携带者,评估母乳喂养时长与卵巢癌风险的关系。总体曾母乳喂养的合并OR为0.767(95%CI 0.688-0.856);BRCA1突变携带者中曾母乳喂养显著预防卵巢癌,而BRCA2突变携带者需母乳喂养超过1年才降低风险。

要点

  • BRCA1突变携带者曾母乳喂养与卵巢癌风险显著降低相关(OR 0.767)。
  • BRCA2突变携带者需母乳喂养超过1年才显示保护作用(OR 0.567)。
  • 母乳喂养是BRCA1/2突变携带者卵巢癌可修改的预防因素。

核心结论

  • 母乳喂养是BRCA1/2突变携带者卵巢癌的预防性可修改因素。
  • BRCA1突变携带者曾母乳喂养即显著预防卵巢癌,BRCA2突变携带者需母乳喂养1年或以上才降低风险。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、EMBASE和Cochrane数据库至2021年6月1日。
  • 纳入1项队列研究和4项病例对照研究,共14,601例BRCA1/2突变携带者。
  • 使用固定效应模型合并比值比(OR)。

主要发现

  • 总体曾母乳喂养的合并OR为0.767(95%CI 0.688-0.856)。
  • BRCA1突变携带者曾母乳喂养的OR为0.817(95%CI 0.650-1.028)。
  • 母乳喂养超过1年在BRCA1突变携带者中OR为0.787(95%CI 0.682-0.907),在BRCA2突变携带者中OR为0.567(95%CI 0.400-0.802)。
  • 无异质性(I2=0%),漏斗图分布对称,无发表偏倚。

临床怎么用

  • 对BRCA1/2突变携带者进行遗传咨询时,可告知母乳喂养对卵巢癌的预防作用。
  • 针对BRCA2突变携带者,建议母乳喂养持续1年或以上以降低卵巢癌风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A recent study showed that even a few months of breastfeeding is associated with a significant decrease in the risk of ovarian cancer in the general population. This study aimed to perform a systematic review and meta-analysis to determine the significance of the length of the breastfeeding period on ovarian cancer risk in BRCA1/2 mutation carriers. METHODS: PubMed, EMBASE, and Cochrane databases were searched up to June 1, 2021. We included case-control and cohort studies that contained information on breastfeeding and the risk of ovarian cancer in BRCA1/2 mutation carriers. Odds ratios (OR) were meta-analytically pooled using a fixed-effects model.dd RESULTS: Five studies, including one cohort study and four case-control studies, were included in this meta-analysis. Of the 14,601 BRCA1/2 mutation carriers, the overall pooled OR of ever having performed breastfeeding in patients who had ovarian cancer was 0.767 (95% confidence interval [CI], 0.688-0.856) and 0.817 (95% CI, 0.650-1.028) for patients with BRCA1 and BRCA2 mutation, respectively. Breastfeeding for >1 year acted as a protective factor in both BRCA1 [OR: 0.787 (95% CI, 0.682-0.907)] and BRCA2 [OR: 0.567 (95% CI, 0.400-0.802)] mutation carriers. No significant heterogeneity was present (I2 = 0%), and the funnel plot was also properly distributed, showing no publication bias. CONCLUSIONS: Breastfeeding is a preventive, modifiable factor for ovarian cancer in BRCA1/2 mutation carriers. Ever having performed breastfeeding was significantly preventive for ovarian cancer in the BRCA1 mutation carriers, however a period of 1 year or more of breastfeeding is required for a reduced ovarian cancer risk in BRCA2 mutation carriers.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Eoh KJ, Park EY, Chang YJ, et al. The preventive effect of breastfeeding against ovarian cancer in BRCA1 and BRCA2 mutation carriers: A systematic review and meta-analysis. Gynecol Oncol. 2021. PMID: 34304906. doi:10.1016/j.ygyno.2021.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。